QPharma Launches Neolytica, an AI-Focused Healthcare Analytics Firm
Driving Data-Driven Decision-Making in the Life Sciences Industry
Morristown, NJ – March 17, 2022 – QPharma, a leading provider of compliance and commercial services to the life sciences industry, has recently launched Neolytica, a new AI-focused healthcare analytics firm.
Neolytica aims to provide advanced data analytics solutions to pharmaceutical, biotech, and medical device companies. Leveraging artificial intelligence and machine learning technologies, Neolytica offers actionable insights and predictive analytics to drive informed decision-making and optimize business strategies in the rapidly evolving healthcare landscape. With its innovative approach and expertise in data analytics, Neolytica is poised to make a significant impact in the industry by helping clients unlock the full potential of their data and drive growth.
